Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · SANOFI

SANOFI

HealthcarePharmaceuticals & Biotechnology₹7443 cr market cap
₹3202.50 ▼ -0.91% today As of 19 Nov 2026
52-week low ₹2772.8052-week high ₹4614.20

-30.0% from the 52-week high · +16.6% above the low

Sanofi India Ltd. engages in the manufacturing and distribution of pharmaceutical drugs. The company is headquartered in Mumbai, Maharashtra and currently employs 3,530 full-time employees. The firm is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The company offers a range of medicines and supplements for treatment of diabetes (both insulin and orals), cardiology, thrombosis, epilepsy, allergies, and infections. The company has two manufacturing sites, one in Hyderabad and one in Goa. Its geographical segments include India, Singapore, and Others. The company sells its products through independent distributors primarily in India. The company also manufactures its products through third party manufacturers. The different types of dosage forms include tablets, capsules (hard and soft), eye/ear drops, ampoules, vials, creams, and ointment. Its brands include Lantus, Allegra, and Combiflam. Its vaccine products include Adacel, Avaxim 80U/160U, FluQuadri, Hexaxim, Menactra, Tetraxim, Vaxigrip, Stamaril, Shanvac-B and ShanTT. Its consumer healthcare products include Allegra, Allegra nasal, and Avil.

The short version. SANOFI reported revenue of ₹515 crore for Dec 2024, down 25.8% from a year earlier. Net profit was ₹91 crore (down 34.1% year on year). Promoter holding was 60.4% in Sep 2026, up 0.00 points over 8 quarters.

1 · The price

How has the stock traded?

SANOFI trades 30.0% below its 52-week high and 16.6% above its 52-week low.

Change over period: —

1M+12.2%
3M-1.2%
6M+1.3%
1Y-29.4%

2 · The business

Is it growing?

Sales, year on year-25.8%

Dec 2024 revenue of ₹515 cr.

Profit, year on year-34.1%

Dec 2024 net profit of ₹91 cr.

Net margin17.7%

2.1 pts lower than a year earlier.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023
Revenue515524464732694715706
Net profit9182103137138152123
Net margin %17.715.722.318.719.821.317.4
EPS (₹)39.6435.6944.8159.3159.7965.9853.36

Annual

Dec 2024Dec 2023
Revenue20132851
Net profit413603
Net margin %20.521.1
EPS (₹)179.46261.78

3 · The quality

How well does it turn capital into profit?

.

Profitability · 4 years

Returns and margins

Dec 2025Dec 2024Dec 2023Dec 2022
Return on equity %—48.059.4—
Return on capital %—48.579.7—
EBITDA margin %—23.130.4—
Net margin %—20.420.7—

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR——
Profit CAGR——
P/E ratio20.5

4 · The owners

Who holds it, and are they adding?

Promoter holding60.4%

Unchanged over 8 quarters.

Foreign institutions5.73%

Up 0.1 pts over 8 quarters.

Domestic institutions19.41%

Down 3.52 pts over 8 quarters.

Mutual fund schemes19

+3 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter60.460.460.460.460.460.460.460.40.0
FII5.635.575.615.575.555.645.695.73+0.1
DII22.9323.0223.0622.2921.3121.1319.8719.41-3.52
Public11.0411.0110.9411.7512.7412.8314.0414.46+3.42

Mutual fund holdings · Oct 2026

19 schemes hold this stock

16 the month before.

  • Bandhan Healthcare Fund1.58% of NAV
  • Abakkus Small Cap Fund1.15% of NAV
  • NIPPON INDIA PHARMA FUND1.06% of NAV
  • Sundaram Dividend Yield Fund0.49% of NAV
  • ADITYA BIRLA SUN LIFE BALANCED ADVANTAGE FUND0.42% of NAV
  • ADITYA BIRLA SUN LIFE LARGE CAP FUND0.39% of NAV
  • SAMCO MULTI CAP FUND0.36% of NAV
  • Bandhan Flexi Cap Fund0.24% of NAV

See what mutual funds are buying

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for SANOFI are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about SANOFI

What is the SANOFI share price?

SANOFI (SANOFI) last closed at ₹3,202.50, down 0.91% on the day. Its 52-week range is ₹2,772.80 to ₹4,614.20.

What is the market cap of SANOFI?

SANOFI has a market capitalisation of about ₹7,443 crore. Its price-to-earnings ratio is 20.5.

How are SANOFI's latest results?

SANOFI reported revenue of ₹515 crore for Dec 2024, down 25.8% from a year earlier. Net profit was ₹91 crore (down 34.1% year on year). Promoter holding was 60.4% in Sep 2026, up 0.00 points over 8 quarters.

Who owns SANOFI?

As of Sep 2026, shareholding was: Promoter 60.4%, FII 5.73%, DII 19.41%, Public 14.46%.

How many mutual funds hold SANOFI?

19 mutual fund schemes held SANOFI in October 2026. That compares with 16 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 22 Apr 2026 · Final Dividend - Rs. 48
  • 07 Nov 2025 · Interim Dividend - Rs. 75
  • 25 Apr 2025 · Final Dividend - Rs. 117
  • 03 May 2024 · Final Dividend - Rs. 117
  • 07 Mar 2024 · Interim Dividend - Rs. 50
  • 28 Apr 2023 · Final Dividend - Rs. 194

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.